PLUS1
TALI Digital Financial Data
| Company name: | Novita Healthcare Ltd | Status: | Active |
| End of fiscal year: | 30 June 2018 | ISIN | AU000000NHL8 |
| Year established: | 2004 | Company sector name: | Technology |
| Trading currency: | AUD | Industry name: | Health Information Services |
| Place of incorporation: | Australia (AU) | Industry group name | Application Software |
| Doing business in: | Australia (AU) | Address | 1 Crescent Road Suite 2, Ground Floor, 3146 |
| Tel.: | +61 391929937 | City/Country: | Melbourne, Australia |
| Fax: | +61 391929937 | Web address: | http://www.novitahealthcare.com.au |
| Company description: | Novita Healthcare Ltd is a medical technology company. The company is engaged in the research and development for commercialisation of medical technology having ceased all drug development activities. The company focus is on the development of TALI Health and the TALI Technology. The company has three reportable segments namely research and development, Healthcare/Workforce, Management, and investments. The company generates maximum revenue from research and development segment. |
| Price | Price change [%] | Bid | Offer | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.052 | 0.00[0.0%] | 0.051 | 0.052 | 0.00 | |||
| Market Cap. [m] | Shares In Issue [m] | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
| 16.191803628 | 449.305165 | 0.37 | -0.01 | - | -3.85 | - | - - - |
NHL KEY FIGURES (at previous day's close) | |
|---|---|
Yesterday's Close | 0.05 |
PE Ratio | -3.85 |
Market Capitalisation | 16.19M |
Latest Shares Outstanding | 449.31M |
Earnings pS (EPS) | -0.01 |
Dividend pS (DPS) | - |
Dividend Yield | - |
Sales per Employee | 6,868.08 |
Effective Tax Rate | - |
Foreign Sales | - |
Domestic Sales | - |
Selling, General & Adm/tive (SG... | 2,851.06% |
Research & Devlopment (R&D) as ... | 0.00% |
Gross Profit Margin | 100.00% |
EBITDA Margin | - |
Pre-Tax Profit Margin | - |
Assets Turnover | 43.90% |
Return on Assets (ROA) | -1.30% |
Return on Equity (ROE) | -1.70% |
Return on Capital Invested (ROC... | -1.72% |
Current Ratio | 2.40 |
Leverage Ratio (Assets/Equity) | 1.47% |
Interest Cover | - |
Total Debt/Equity (Gearing Rati... | - |
LT Debt/Total Capital | - |
Working Capital pS | 0.01 |
Cash pS | 0.00 |
Book-Value pS | 0.01 |
Tangible Book-Value pS | 0.00 |
Cash Flow pS | - |
Free Cash Flow pS | -0.01 |
Spread | 0.00 |
Gross gearing | 0.00% |
Net Debt | -1.16M |
NHL Balance Sheet Chart (30 June 2018) | ||
|---|---|---|
 | ||
| Period † | High | Low |
|---|---|---|
| 1 Week | 0.00 | 0.00 |
| 1 Month | 0.00 | 0.00 |
| 3 Months | 0.00 | 0.00 |
| 6 Months | 0.00 | 0.00 |
| 1 Year | 0.00 | 0.00 |
| 3 Years | 0.105 | 0.009 |
| 5 Years | 0.105 | 0.009 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| Period † | Open | Open Avg. | VWAP | Min Vol | Max Vol | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0% |
| 3 Years | 0.028 | 0.029669 | 0.066235 | 2,422 | 377,010,663 | 29,085,106 | 0.024 | 85.71% |
| 5 Years | 0.034 | 0.032871 | 0.063862 | 178 | 377,010,663 | 8,263,320 | 0.018 | 52.94% |
NHL Growth Ratios (30 June 2018) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | -0.32 | -0.59 | -0.51 | -0.43 |
Revenue growth | - | - | - | -0.21 |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | - | - | - | -0.21 |
NHL Income Statement 30 June 2018 (AUD) | |
|---|---|
Total Revenue | 0.089285 |
Operating Revenue | 0.089285 |
Gross Profit | 0.089285 |
Operating Expenses | 3.904931 |
Selling,General and Administr... | 2.545572 |
General and Administrative Ex... | 2.131335 |
Salary and Benefit | 1.827064 |
Rent and Landing Fees | 0.103565 |
OtherGandA | 0.200706 |
Selling and Marketing Expense | 0.414237 |
Research and Development | 0.396142 |
Depreciation,Amortization and... | 0.247303 |
Depreciation and Amortization | 0.247303 |
Depreciation | 0.025585 |
Amortization | 0.221718 |
Amortization of Intangibles | 0.221718 |
Other Operating Expenses | 0.715914 |
Operating Income | -3.815646 |
Interest Income/Expense,Net-N... | 0.034533 |
Interest Income-Non Operating | 0.034533 |
Other Income/Expense,Net | -0.412085 |
Special Income/Charges | -0.923202 |
Impairment of Capital Assets | 0.923202 |
Other Non-Operating Income/Ex... | 0.511117 |
Pretax Income | -4.193198 |
Provision for Income Tax | 0.00 |
Net Income Available to Commo... | -4.193198 |
Net Income | -4.193198 |
Net Income Including Noncontr... | -4.193198 |
Net Income from Continuing Op... | -4.193198 |
Basic EPS | -0.01 |
Basic EPS from Continuing Ope... | -0.01 |
Basic EPS from Discontinued O... | 0.00 |
Diluted EPS | -0.01 |
Diluted EPS from Continuing O... | -0.01 |
Diluted EPS from Discontinued... | 0.00 |
Basic Weighted Average Shares... | 311.380839 |
Diluted Weighted Average Shar... | 311.380839 |
Net Income from Continuing an... | -4.193198 |
Normalized Income | -3.269996 |
Basic EPS,Continuing and Disc... | -0.01 |
Diluted EPS,Continuing and Di... | -0.01 |
Interest and Dividend Income | 0.034533 |
Net Interest Income | 0.034533 |
Earning Before Interest and T... | -3.815646 |
Earning Before Interest Tax D... | -3.568343 |
Depreciation,Reconciled | 0.247303 |
Net Income from Continuing Op... | -4.193198 |
TotalUnusualItemsExcludingGoo... | -0.923202 |
TotalUnusualItems | -0.923202 |
Normalized Basic EPS | -0.01 |
Normalized Diluted EPS | -0.01 |
NormalizedEBITDA | -2.645141 |
Tax rate for calculations | 0.00 |
NHL Efficency Ratios (30 June 2018) | |
|---|---|
Days in sales | 332.66 |
Days in inventory | - |
Days in payment | - |
Cash conversion cycle | - |
Receivable turnover | 1.10 |
Inventory turnover | - |
Payable turnover | - |
Fixed assets turnover | 1.52 |
Assets turnover | 0.03 |
ROE | -1.70 |
ROA | -1.30 |
ROIC | -1.72 |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | 13.68 |
NHL Financial Health Ratios (30 June 2018) | |
|---|---|
Current ratio | 2.40 |
Quick ratio | 2.39 |
Debt total capital ratio | - |
Debt equity ratio | - |
Financial leverage | 1.47 |
Total debt to equity | - |
NHL Avearge Growth Ratios Over 5 Years (30 June 2018) | |
|---|---|
Growth ann capital spending | 1.61 |
Growth ann gross profit | - |
Avg gross margin | - |
Avg post tax margin | - |
Avg pre tax marginr | - |
Avg net profit | - |
Avg ret commonr | -1.03 |
Avg ret assets | -0.89 |
Avg ret invested capital | -1.05 |
NHL Profitability Ratios (30 June 2018) | |
|---|---|
Gross margin | 1.00 |
Operating margin | -42.74 |
EBT margin | -46.96 |
Tax rate | - |
Net margin | -46.96 |
Sales per employee | 6,868.08 |
EBIT margin | -42.74 |
EBITDA margin | -39.97 |
Normalized net profit margin | -36.62 |
Interest coverage | - |
Inc per employee tot ops | - |
NHL Valuation Ratios (29 June 2018) | |
|---|---|
Sales per share | - |
Growth ann sales per share 5 ye... | - |
Book value per share | 0.02 |
CF per share | -0.00 |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | 2.31 |
Price to sales | - |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | 0.00 |
Sustainable growth rate | -0.74 |
Cash return | -0.20 |
NHL Balance Sheet 30 June 2018 (AUD) | |
|---|---|
Total Assets | 3.919813 |
Current Assets | 2.015094 |
Cash,Cash Equivalents,and Sho... | 1.186034 |
Cash and Cash Equivalents | 1.161458 |
Cash | 0.176036 |
Cash Equivalents | 0.985422 |
Short Term Investments | 0.024576 |
Receivables | 0.814886 |
Accounts Receivable | 0.08067 |
Other Receivables | 0.734216 |
Prepaid Assets and Others | 0.014174 |
Total Non-Current Assets | 1.904719 |
Net Property,Plant,and Equipm... | 0.065654 |
Gross Property,Plant,and Equi... | 0.177136 |
Machinery,Furniture/Equipment | 0.177134 |
Other Properties | 2.00 |
Accumulated Depreciation | -0.111482 |
Goodwill and Other Intangible... | 1.839065 |
Other Intangible Assets | 1.839065 |
Total Liabilities | 1.258887 |
Current Liabilities | 0.838 |
Payables and Accrued Expenses | 0.604597 |
Payables | 0.604597 |
Accounts Payable | 0.604597 |
Pension and Other Post-Retire... | 0.104585 |
Deferred Liabilities,Current | 0.072789 |
Deferred Revenue,Current | 0.072789 |
Other Current Liabilities | 0.056029 |
Total Non-Current Liabilities | 0.420887 |
Deferred Liabilities, Non cur... | 0.418534 |
Deferred Revenues,Non-Current | 0.418534 |
Employee Benefits | 2,353.00 |
Pension and Other Postretirem... | 2,353.00 |
Total Equity | 2.660926 |
Stockholder's Equity | 2.660926 |
Capital Stock | 192.495917 |
Common Stock | 192.495917 |
Retained Earnings | -190.203096 |
Accumulated Gains/ Losses Not... | 0.368105 |
Other Equity Adjustments | 0.368105 |
Total Capitalization | 2.660926 |
Common Stock Equity | 2.660926 |
Net Tangible Assets | 0.821861 |
Working Capital | 1.177094 |
Invested Capital | 2.660926 |
Tangible Book Value | 0.821861 |
Ordinary Shares Number | 359.444132 |
TotalLiabilitiesAsReported | 1.258887 |
TotalEquityAsReported | 2.660926 |
NHL Cash Flow 30 June 2018 (AUD) | |
|---|---|
Classes of Cash Receipts from... | 0.760767 |
Receipts from Customers | 0.069499 |
Receipts from Government Gran... | 0.18692 |
Other Cash Receipts from Oper... | 0.504348 |
Classes of Cash Payments | -2.55487 |
Payments to Suppliers for Goo... | -2.55487 |
Interest Received, Direct | 0.031999 |
Cash Flow from Investing Acti... | -1.121995 |
Cash Flow from Continuing Inv... | -1.121995 |
Purchase/Sale of Property,Pla... | -0.044237 |
Purchase of Property,Plant an... | -0.044237 |
Purchase/Sale of Intangibles,... | -1.177494 |
Purchase of Intangibles | -1.177494 |
Purchase/Sale of Investments,... | 0.099736 |
Sale of Investments | 0.099736 |
Cash Flow from Financing Acti... | 3.14498 |
Cash Flow from Continuing Fin... | 3.14498 |
Issuance/Payments of Common S... | 3.14498 |
Proceeds or Issuance of Commo... | 3.517498 |
Payments for Common Stock | -0.372518 |
Cash and Cash Equivalents,End... | 1.201898 |
Change in Cash | 0.260881 |
Cash and Cash Equivalents,Beg... | 0.941017 |
Capital Expenditure | -1.221731 |
Issuance of Capital Stock | 3.517498 |
Repurchase of Capital Stock | -0.372518 |
Free Cash Flow | -2.983835 |
ChangeinCashSupplementalAsRep... | 0.260881 |
